Illumina, Inc. ILMN today announced it was awarded a contract from
the U.S. Food and Drug Administration (FDA) to provide the agency with MiSeq
sequencing systems and reagents for conducting whole genome analysis on
produce and produce-related environmental Salmonella and shigatoxigenic E.
coli isolates. The contract is worth up to $17 million over a period of five
years.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in